Find the protocol that fits your program.
Match your question to a characterized readout.
All four applications share the same lot-release criteria and characterization package, so switching between research areas within a program does not require re-qualification of the biological substrate.
Viability & IC50
Colony Formation
Flow Cytometry
Cytokine Secretion
Hemato-Oncology Drug Screening
Bone Marrow Toxicity Prediction
Disease-Microenvironment Biology
Combination Therapy Profiling
Dose-response profiling of small molecules and biologics in disease-specific stromal microenvironments. Lot-characterized models enable direct compound comparisons across independent runs.
Multiplex secretion panels measure synergistic or antagonistic cytokine responses when two agents are co-administered, supporting rational schedule optimization before in vivo studies.
Hematopoietic progenitor colony assays within intact stromal architecture identify myelosuppressive liability earlier than 2D culture or animal-derived data alone.
Immunophenotyping and stromal crosstalk studies in AML and MDS niche architectures, with cell-population readouts traceable to primary patient sample profiles.
